previous compound ID: 1190 next compound
InChIKey: KPSRODZRAIWAKH-UHFFFAOYSA-N
SMILES: CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CC2(Cl)Cl

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Goepp" "D Rotin" "JW Hanrahan" "B Kus" "J Liao" "SD Macknight" "E Matthes" "GW Carlile" "DY Thomas" "R Robert"

chemical graph of compound 1190





CID is 2763
synonyms found at PubChem are:
Ciprofibrate, 52214-84-3, Lipanor, 2-(4-(2,2-dichlorocyclopropyl)phenoxy)-2-methylpropanoic acid, Ciprofibratum, Ciprofibrato, Modalim, Oroxadin, 2-[4-(2,2-Dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid, Ciprofibratum [INN-Latin], Ciprofibrato [INN-Spanish], Hiperlipen, Ciprol, Win-35833, WIN 35833, CCRIS 173, C13H14Cl2O3, Ciprofibrate [USAN:BAN:INN], Win 35,833, EINECS 257-744-6, Ciprofibrate (USAN/INN), BRN 1984981, 2-(4-(2,2-Dichlorocyclopropyl)phenoxy)2-methylpropanoic acid, 2-(p-(2,2-Dichlorocyclopropyl)phenoxy)-2-methylpropionic acid, CHEBI:50867, KPSRODZRAIWAKH-UHFFFAOYSA-N, Propanoic acid, 2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methyl-, NCGC00164447-01, 2-[p-(2,2-Dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid, 2-{[4-(2,2-dichlorocyclopropyl)phenyl]oxy}-2-methylpropanoic acid, DSSTox_CID_331, Propanoic acid, 2-(4-(2,2-dichlorocyclopropyl)phenoxy)-2-methyl-, C 0330, DSSTox_RID_75519, DSSTox_GSID_20331, Hyperlipen, 2-{4-[2,2-dichlorocyclopropyl]phenoxy}-2-methylpropanoic acid, SMR000857190, SR-01000075734, 2-[p-(2,2-dichlorocyclopropyl)phenoxy]-2-methylpropionic acid, Ciprofibrate?, Ciprofibrate [USAN:INN:BAN], CAS-52214-84-3, AC1L1EET, Prestwick0_001076, Prestwick1_001076, Prestwick2_001076, Prestwick3_001076, D0EJ6O, Lopac0_000168, SCHEMBL26870, BSPBio_001092, MLS002154143, MLS006011758, SPBio_002996, 2-[4-(2,2-dichlorocyclopropyl)phenoxy]isobutyric acid, BPBio1_001202, CHEMBL557555, GTPL3438, DTXSID8020331, CTK7I5107, KS-00000FXC, AOB6803, MolPort-003-666-795, BCPP000277, HMS1571G14, HMS2098G14, HMS2235J14, HMS3260B17, HMS3369B22, HMS3656P09, HMS3715G14, Pharmakon1600-01502008, BCP03728, EBD38709, HY-B0664, Tox21_112121, Tox21_201359, Tox21_302840, Tox21_500168, AN-880, ANW-46062, BBL010821, BDBM50371235, BG0457, MFCD00467135, NSC759617, s2665, Sanofi Winthrop brand of ciprofibrate, STK624758, AKOS005557843, Tox21_112121_1, AC-1018, API0002026, BCP9000533, CCG-204263, CS-2898, KS-1201, LP00168, LS-7279, MCULE-8060052925, NSC-759617, RP29995, Sanofi Synthelabo brand of ciprofibrate, NCGC00015202-02, NCGC00015202-03, NCGC00015202-04, NCGC00015202-05, NCGC00015202-06, NCGC00015202-08, NCGC00093652-01, NCGC00093652-02, NCGC00256361-01, NCGC00258911-01, NCGC00260853-01, 4CA-0385, AK-77509, BC207557, CC-25814, BCP0726000148, AB0010540, AB2000704, AX8121411, KB-222047, RT-004891, AB00514032, EU-0100168, FT-0602946, ST24027521, D03521, AB00514032_06, 214C843, A828985, C-18160, I14-0695, J-520054, SR-01000075734-1, SR-01000075734-4, SR-01000075734-7, BRD-A49358627-001-03-9, BRD-A49358627-001-10-4, 2-[4-(2,2-Dichlorocyclopropyl)phenoxy]-2-methylpropionic Acid, Ciprofibrate, European Pharmacopoeia (EP) Reference Standard, 2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methyl-propanoic acid, Propionic acid, 2-(4-(2,2-dichlorocyclopropyl)phenoxy)-2-methyl-, 2-[4-[2,2-bis(chloranyl)cyclopropyl]phenoxy]-2-methyl-propanoic acid, Ciprofibrate for system suitability, European Pharmacopoeia (EP) Reference Standard